As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...
Studies on COVID, climate change and South Africa are on the latest list of terminated grants by the U.S. National Institutes ...
Ensitrelvir reduced transmission of SARS-CoV-2 by 67% when given to uninfected household contacts of a person with COVID-19 ...
Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., have described a next-generation vaccination technology ...
In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.
It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about its future evolution remain.
The COVID-19 pandemic showed in real time, and with the highest of stakes, how hard it can be to decide if something is true.
NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has unveiled promising preclinical and Phase 1 data for ratutrelvir, its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results